Flagship Biotech International Private Limited was founded in the year 2008. As a company it is committed towards affordable health care. With presence in about 70 countries it has more than 400+ registered formulations under its brand and more than 700 pharmaceuticals formulations. The company’s manufacturing plants are certified by leading regulatory authorities like WHO-cGMP, EU(CE), US-FDA-Health Canada-PICs- MCC(for Beta lactum,Cephalosporin & Clavulanate injection only)PPB Kenya NAFDAC etc. Being a young and dynamic company it always showcased an inclination towards pharmaceutical research. The company is headquartered in Mumbai and it is well integrated with Strong brand equity in multiple therapeutic categories such as Oncology, Gastroenterology, Neurology, Thyroid, diabetes & Urology, Pain Management, Vitamins, Anti-infective &other Therapy areas. Flagship Biotech International stood among top 100 out of 70,000 companies to receive Axis Bank SME Award, It is also awarded the Fastest Growing Pharma Company in exports the Most Admired Pharma Company in Exports by Pharma Excellence Award Council of India. The efforts and commitment of the company towards industry are also recognized by govt. of India which awarded it as a star export house of India. Flagship Biotech International is a government of India recognized-"Star Export House" which growing at a phenomenal rate of over 70% per annum since last 8 years it is not only considered about profits but also about the society around it. They channeled their CSR activities through various foundation. The founders with more than 15+ years industry experience always backed the employees which helped them to have a motivated and committed team that ensured success year after year and made the company to achieve unscalable heights of growth.
United Arab Emirates
India
Germany
